Scholars Central

Conference abstract

Riboflavin supplementation improves neurological disability but not spatial cognition mediated with increased gene expression and protein levels of BDNF in the brain and spinal cord in murine model of multiple sclerosis

Authors: Mahshid Naghashpour, Reza Amani, Alireza Sarkaki, Ata allah Ghadiri, Alireza Samarbafzadeh, Ahmad Rouhizadeh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Interferon beta-1A (IFNβ-1A) is the major treatment for MS. However, this treatment is not always effective. It has been showed that riboflavin is important in the myelin formation. The interactions between potential effects of riboflavin and IFNβ-1A on neurological disability, learning and memory as well as the gene expression and protein levels of brain-derived neurotrophic factor (BDNF) in the brain and spinal cord of experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS) were evaluated. Methods: Fifty-six female C57BL/6 mice at +10 weeks of age underwent EAE induction. Riboflavin at 10 mg/Kg of body weight and/or IFNβ-1A at 150 IU/g of body weight were administrated for two weeks. The mice (n=56) were assigned into7 groups randomly (with 8 in each): sham operated 1 [SO1], PBS; sham operated 2 [SO2], PBS+riboflavin; sham treatment 1 [ST1], EAE+same volume of water (as vehicle of riboflavin); sham treatment 2 [ST2] EAE+sodium acetate buffer (as vehicle of IFNβ-1A); treatment 1 [T1], EAE+IFNβ-1A; treatment 2 [T2], EAE+riboflavin; treatment 3 [T3], EAE+IFNβ-1A+riboflavin. mRNA was quantitated for BDNF using Real-time PCR system. Levels of the BDNF were quantified using the BDNF EMAX® ImmunoAssay System. Spatial learning and memory were assessed using the standard Morris water maze (MWM). Results: Treatment the EAE mice with combination of the riboflavin and IFNβ-1A improved neurological disability significantly (P<0.01) by increasing the gene expression and BDNF level in both brain and spinal cord of EAE mice. T2 Mice treated with riboflavin swam significantly faster than ST2 and T1 mice. T3 mice treated with both riboflavin and INFβ-1A swam significantly faster than ST1 mice on day 4 of the trial (P=0.003). Conclusion: Our findings address the therapeutic effects of riboflavin and highlight the synergistic role of riboflavin with IFN- β1A on neurological disability improvement probably mediated by BDNF levels in the brain and spinal cord in an experimental model of MS.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Neurological Disorders.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeurological Disorders
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Mahshid Naghashpour”
  • BylineArticles whose byline prints “Reza Amani”
  • BylineArticles whose byline prints “Alireza Sarkaki”
  • BylineArticles whose byline prints “Ata allah Ghadiri”
  • BylineArticles whose byline prints “Alireza Samarbafzadeh”
  • BylineArticles whose byline prints “Ahmad Rouhizadeh”